- John L. Cassis
- New Brunswick, New Jersey
- Pharmaceutical, Consumer, Medical Device, Health Care, Biotechnology
- Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.
JJDC plays an integral role in the identification of new business opportunities outside of Johnson & Johnson’s traditional portfolio and market presence. JJDC identifies new market opportunities and develops new businesses in emergent health care sectors while also creating support venture investments in alignment with the strategic objectives of Johnson & Johnson operating companies.
Current Team (10)Update
|Jan 14, 2016||PRNewswire All - Renova Therapeutics appoints Richard 'Mac' McCloskey to head company's clinical development efforts|
|Jun 22, 2015||Xconomy - 25 Years in Biotech|
|Jun 20, 2015||PRNewswire All - Tetra Discovery Partners Announces Additional Financing and Formation of Scientific Advisory Board|
|Jun 19, 2014||Beta Boston - J&J announces deals with six Boston biotech firms|
|May 29, 2014||FinSMEs - Rodin Therapeutics Closes $12.9M Series A Financing Round|
|Jun 21, 2012||TechCrunch - Do Patents Really Matter To Startups? New Data Reveals Shifting Habits|
|Jan 5, 2011||Xconomy - SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News|
|Jan 3, 2011||Xconomy - Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business|
410 George Street
New Brunswick, New Jersey 08901
Menlo Park, California